Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
Study NCT ID:
NCT04185220
Status:
COMPLETED
Last Update Posted:
2023-01-04
First Post:
2019-12-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
Sponsor:
Organization: